Physical Functional Capacity and C-Reactive Protein in schizophrenia
Introduction: Schizophrenia is a severe, debilitating mental disorder that affects both the physical health and the functional capacity of patients, causing great impairment throughout the life course. Although physical and cognitive impairments may represent different expressions of a single system...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2016.00131/full |
_version_ | 1818855723696652288 |
---|---|
author | Michele Fonseca Szortyka Viviane Cristiano Keila Cereser Lenise Francesconi Maria Ines Lobato Clarissa Gama Paulo Abreu |
author_facet | Michele Fonseca Szortyka Viviane Cristiano Keila Cereser Lenise Francesconi Maria Ines Lobato Clarissa Gama Paulo Abreu |
author_sort | Michele Fonseca Szortyka |
collection | DOAJ |
description | Introduction: Schizophrenia is a severe, debilitating mental disorder that affects both the physical health and the functional capacity of patients, causing great impairment throughout the life course. Although physical and cognitive impairments may represent different expressions of a single systemic inflammatory process, little is known about the relationship between motor function and schizophrenia.Objective: To evaluate physical functional capacity in patients with schizophrenia and ascertain whether it correlates with markers of inflammation, disease severity, and pharmacotherapy.Methods: Cross-sectional study using a convenience sampling strategy. Forty patients with stable schizophrenia, undergoing treatment, were recruited from the Outpatient Program of Hospital de Clínicas de Porto Alegre, University Hospital linked to Public Health System. Physical functional capacity was assessed by the 6-minute walk test (6MWT), and inflammatory markers were measured by C - reactive protein (CRP) and Von Willebrand Factor (VWF). Results: Mean functional capacity and clinical variables differed among patients and Brazilian population regarding heart rate (p=0.004), diastolic (p=0.001) and systolic (p<0.001) blood pressure, respiratory rate (p<0.001), CRP (p=0.015), Borg Scale of Perceived Exertion scores (p<0.001), and 6MWT both in men (p<0.001) and women (p=0.024). Additionally, 6MWT and dyspnea in Borg Scale of Perceived Exertion scores (BSPE) were positively associated to CRP (r=-.369, p=.019) and r=-.376, p=.017) and r=0.354, p=0.025 and r=0.535, p<0.001, respectively).Conclusion: The present study detected significant association between measures of functional impairment and markers of inflammation, especially elevated CRP in a group of stable outpatients with DSM-IV and ICD10 diagnosis of schizophrenia. Possible explanations for the associations could be linked to continued use of antipsychotics, although underlying neuroinflammatory mechanisms directly related to illness (schizophrenia) could not be ruled out. The findings of this study expand evidences of neuroinflammation to systemic inflammation in schizophrenia linking it to alterations of physical functional capacity and point to the need of additional studies exploring general inflammation and novel therapeutic interventions. |
first_indexed | 2024-12-19T08:13:08Z |
format | Article |
id | doaj.art-8e95c91f4d6c4be8bdabf636f96dc442 |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-12-19T08:13:08Z |
publishDate | 2016-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-8e95c91f4d6c4be8bdabf636f96dc4422022-12-21T20:29:34ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402016-08-01710.3389/fpsyt.2016.00131203230Physical Functional Capacity and C-Reactive Protein in schizophreniaMichele Fonseca Szortyka0Viviane Cristiano1Keila Cereser2Lenise Francesconi3Maria Ines Lobato4Clarissa Gama5Paulo Abreu6UFRGSUFRGSUFRGSUFRGSUFRGSUFRGSUFRGSIntroduction: Schizophrenia is a severe, debilitating mental disorder that affects both the physical health and the functional capacity of patients, causing great impairment throughout the life course. Although physical and cognitive impairments may represent different expressions of a single systemic inflammatory process, little is known about the relationship between motor function and schizophrenia.Objective: To evaluate physical functional capacity in patients with schizophrenia and ascertain whether it correlates with markers of inflammation, disease severity, and pharmacotherapy.Methods: Cross-sectional study using a convenience sampling strategy. Forty patients with stable schizophrenia, undergoing treatment, were recruited from the Outpatient Program of Hospital de Clínicas de Porto Alegre, University Hospital linked to Public Health System. Physical functional capacity was assessed by the 6-minute walk test (6MWT), and inflammatory markers were measured by C - reactive protein (CRP) and Von Willebrand Factor (VWF). Results: Mean functional capacity and clinical variables differed among patients and Brazilian population regarding heart rate (p=0.004), diastolic (p=0.001) and systolic (p<0.001) blood pressure, respiratory rate (p<0.001), CRP (p=0.015), Borg Scale of Perceived Exertion scores (p<0.001), and 6MWT both in men (p<0.001) and women (p=0.024). Additionally, 6MWT and dyspnea in Borg Scale of Perceived Exertion scores (BSPE) were positively associated to CRP (r=-.369, p=.019) and r=-.376, p=.017) and r=0.354, p=0.025 and r=0.535, p<0.001, respectively).Conclusion: The present study detected significant association between measures of functional impairment and markers of inflammation, especially elevated CRP in a group of stable outpatients with DSM-IV and ICD10 diagnosis of schizophrenia. Possible explanations for the associations could be linked to continued use of antipsychotics, although underlying neuroinflammatory mechanisms directly related to illness (schizophrenia) could not be ruled out. The findings of this study expand evidences of neuroinflammation to systemic inflammation in schizophrenia linking it to alterations of physical functional capacity and point to the need of additional studies exploring general inflammation and novel therapeutic interventions.http://journal.frontiersin.org/Journal/10.3389/fpsyt.2016.00131/fullC-Reactive ProteinPsychiatrySchizophreniamental disorderfunctional capacity |
spellingShingle | Michele Fonseca Szortyka Viviane Cristiano Keila Cereser Lenise Francesconi Maria Ines Lobato Clarissa Gama Paulo Abreu Physical Functional Capacity and C-Reactive Protein in schizophrenia Frontiers in Psychiatry C-Reactive Protein Psychiatry Schizophrenia mental disorder functional capacity |
title | Physical Functional Capacity and C-Reactive Protein in schizophrenia |
title_full | Physical Functional Capacity and C-Reactive Protein in schizophrenia |
title_fullStr | Physical Functional Capacity and C-Reactive Protein in schizophrenia |
title_full_unstemmed | Physical Functional Capacity and C-Reactive Protein in schizophrenia |
title_short | Physical Functional Capacity and C-Reactive Protein in schizophrenia |
title_sort | physical functional capacity and c reactive protein in schizophrenia |
topic | C-Reactive Protein Psychiatry Schizophrenia mental disorder functional capacity |
url | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2016.00131/full |
work_keys_str_mv | AT michelefonsecaszortyka physicalfunctionalcapacityandcreactiveproteininschizophrenia AT vivianecristiano physicalfunctionalcapacityandcreactiveproteininschizophrenia AT keilacereser physicalfunctionalcapacityandcreactiveproteininschizophrenia AT lenisefrancesconi physicalfunctionalcapacityandcreactiveproteininschizophrenia AT mariaineslobato physicalfunctionalcapacityandcreactiveproteininschizophrenia AT clarissagama physicalfunctionalcapacityandcreactiveproteininschizophrenia AT pauloabreu physicalfunctionalcapacityandcreactiveproteininschizophrenia |